From: A gene expression signature associated with survival in metastatic melanoma
Characteristic | Patients (N = 38) | |
---|---|---|
Gender | # | % |
   Male | 18 | 47 |
   Female | 20 | 53 |
Age | Â | Â |
   Median | 58 |  |
   Range | 23–82 |  |
Stage III* | 22 | 58 |
Stage IV* | 16 | 42 |
Previous Treatment** | Â | Â |
   No | 25 | 66 |
   Yes** | 13 | 34 |
   Interferon*** | 9 | 69 |
   Chemotherapy | 5 | 38 |
   Isolated Perfusion | 2 | 15 |
   Radiotherapy | 1 | 7 |